Industry

Meg Harrison, MA

Meg Harrison

Genentech, A Member of the Roche Group
Patient Advocacy Relations

In Patient Advocacy Relations, Meg leads Genentech's engagements with lung, kidney, prostate and bladder cancer patient advocacy groups and contributes to critical business needs including partnerships in biomarker testing as well as Genentech's novel MyInfoMyWay launch that will support lung cancer patient navigation.

HEC member category

Keith Dawson, DNP, MS

Keith Dawson

Genentech, A Member of the Roche Group
Health Equity & Population Science, PD Portfolio Strategy & Execution

Keith leads Clinical Development & Medical Evidence Generation strategy to broaden population specific insights and evidence generation across the drug development lifecycle for Roche.

HEC member category